Jung Ho Jeon1, Byeong Gon Yun1, Min Jae Lim1, Seok Jung Kim2, Mi Hyun Lim1, Jung Yeon Lim1, Sun Hwa Park1, Sung Won Kim3. 1. Department of Biomedicine and Health Science, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea. 2. Orthopedic Department, Uijeongbu St. Mary's Hospital, 271 Cheonbo-ro, Uijeongbu-si, Gyeonggi-do, 11765, Republic of Korea. 3. Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 06591, Korea. kswent@catholic.ac.kr.
Abstract
BACKGROUND: Cell-based therapies have been studied for articular cartilage regeneration. Articular cartilage defects have little treatments because articular cartilage was limited regenerative capacity. Damaged articular cartilage is difficult to obtain a successful therapeutic effect. In additionally these articular cartilage defects often cause osteoarthritis. Chondrocyte implantation is a widely available therapy used for regeneration of articular cartilage because this tissue has poor repair capacity after injury. Human nasal septum-drived chondrocytes (hNCs) from the septum show greater proliferation ability and chondrogenic capacity than human articular chondrocytes (hACs), even across different donors with different ages. Moreover, the chondrogenic properties of hNCs can be maintained after extensive culture expansion. METHODS: In this study, 2 dimensional (2D) monolayer cultured hNCs (hNCs-2D) and 3 dimensional (3D) spheroids cultured hNCs (hNCs-3D) were examined for chondrogenic capacity in vitro by PCR and immunofluorescence staining for chondrogenic marker, cell survival during cultured and for cartilage regeneration ability in vivo in a rat osteochondral defect model. RESULTS: hNCs-3D showed higher viability and more uniform morphology than 3D spheroids cultured hACs (hACs-3D) in culture. hNCs-3D also showed greater expression levels of the chondrocyte-specific marker Type II collagen (COL2A1) and sex-determining region Y (SRY)-box 9 (SOX9) than hNCs-2D. hNCs-3D also expressed chondrogenic markers in collagen. Specially, in the osteochondral defect model, implantation of hNCs-3D led to greater chondrogenic repair of focal cartilage defects in rats than implantation of hNCs-2D. CONCLUSION: These data suggest that hNCs-3D are valuable therapeutic agents for repair and regeneration of cartilage defects.
BACKGROUND: Cell-based therapies have been studied for articular cartilage regeneration. Articular cartilage defects have little treatments because articular cartilage was limited regenerative capacity. Damaged articular cartilage is difficult to obtain a successful therapeutic effect. In additionally these articular cartilage defects often cause osteoarthritis. Chondrocyte implantation is a widely available therapy used for regeneration of articular cartilage because this tissue has poor repair capacity after injury. Human nasal septum-drived chondrocytes (hNCs) from the septum show greater proliferation ability and chondrogenic capacity than human articular chondrocytes (hACs), even across different donors with different ages. Moreover, the chondrogenic properties of hNCs can be maintained after extensive culture expansion. METHODS: In this study, 2 dimensional (2D) monolayer cultured hNCs (hNCs-2D) and 3 dimensional (3D) spheroids cultured hNCs (hNCs-3D) were examined for chondrogenic capacity in vitro by PCR and immunofluorescence staining for chondrogenic marker, cell survival during cultured and for cartilage regeneration ability in vivo in a ratosteochondral defect model. RESULTS: hNCs-3D showed higher viability and more uniform morphology than 3D spheroids cultured hACs (hACs-3D) in culture. hNCs-3D also showed greater expression levels of the chondrocyte-specific marker Type II collagen (COL2A1) and sex-determining region Y (SRY)-box 9 (SOX9) than hNCs-2D. hNCs-3D also expressed chondrogenic markers in collagen. Specially, in the osteochondral defect model, implantation of hNCs-3D led to greater chondrogenic repair of focal cartilage defects in rats than implantation of hNCs-2D. CONCLUSION: These data suggest that hNCs-3D are valuable therapeutic agents for repair and regeneration of cartilage defects.
Authors: Kathryn Futrega; James S Palmer; Mackenzie Kinney; William B Lott; Mark D Ungrin; Peter W Zandstra; Michael R Doran Journal: Biomaterials Date: 2015-05-20 Impact factor: 12.479
Authors: Wa'el Kafienah; Marcel Jakob; Olivier Démarteau; Astrid Frazer; Michael D Barker; Ivan Martin; Anthony P Hollander Journal: Tissue Eng Date: 2002-10
Authors: Nicole Rotter; Lawrence J Bonassar; Geoffrey Tobias; Martin Lebl; Amit K Roy; Charles A Vacanti Journal: Biomaterials Date: 2002-08 Impact factor: 12.479
Authors: Brandon D Markway; Guak-Kim Tan; Gary Brooke; James E Hudson; Justin J Cooper-White; Michael R Doran Journal: Cell Transplant Date: 2009-10-29 Impact factor: 4.064
Authors: Anamarija Rogina; Maja Pušić; Lucija Štefan; Alan Ivković; Inga Urlić; Marica Ivanković; Hrvoje Ivanković Journal: Ann Biomed Eng Date: 2021-01-06 Impact factor: 3.934
Authors: Mi Hyun Lim; Jung Ho Jeun; Do Hyun Kim; Sun Hwa Park; Seok-Jung Kim; Weon Sun Lee; Se Hwan Hwang; Jung Yeon Lim; Sung Won Kim Journal: Tissue Eng Regen Med Date: 2020-05-12 Impact factor: 4.169
Authors: Gabriela S Kronemberger; Fabiana A Carneiro; Danielle F Rezende; Leandra S Baptista Journal: Artif Organs Date: 2021-01-10 Impact factor: 2.663